Why analysts are watching it
Analysts are watching JNJ partly due to its significant distance from previous highs, with Jeremy Lefebvre stating on May 7, 2026, in his video "You will never get a chance like this again‼️" that JNJ is "25% from all-time highs." However, there's debate regarding its role in emerging markets. On May 17, 2026, in his video "Trump Just Opened Up A $400 BILLION Market (Get In Now)?", Felix & Friends questioned if it's "the psychedelic opportunity," despite acknowledging that a drug "everybody said would flop is now doing $2 billion a year" and that Bloomberg called one of their products a "blockbuster psychedelic drug." Nonetheless, Felix & Friends noted that even a successful drug making "$2 billion a year" would "barely moves the stock" of a company as massive as JNJ. Investors should be aware that the overall sentiment from these analyses is bearish on JNJ's potential for significant growth, especially in new markets.
Contributing creators
Source clips
"Johnson & Johnson 25% from [362s] all-time highs."
— You will never get a chance like this again‼️
"I tell you why. I don't think Johnson and Johnson is the psychedelic opportunity."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"But before you run out and buy Johnson and Johnson, I did tell you I'd already bought it."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"The drug Johnson and Johnson built that everybody said would flop is now doing $2 billion a year."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"it's not going to 10x Johnson and Johnson, right?"
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"and Johnson and Johnson might just be like, "Yeah, we really don't like this.""
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"And Johnson and Johnson had wasted years of R&D on a dead product."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"This little case study here, this Johnson Johnson case study is going to be very important to understand the maths later to show you the 10x potential in this sector."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"If Compass got anywhere near to like Johnson Johnson and Johnson's numbers because Johnson and Johnson is guiding to for 5 billion sales a year, you'd be looking at well some pretty crazy stuff right now."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"Bloomberg just called it Johnson and Johnson's blockbuster psychedelic drug."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"It's already happening at another stock which is a teeny tiny little company called Johnson and Johnson."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"Johnson Shell essentially doesn't even know they have this drug called Sprobato."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"It is a massive, massive company. them selling an extra $2 billion on the drug barely moves the stock."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"So Johnson and Johnson, they got FDA approval in 2019 and it's for a drug that's called Sprat or something like that."
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"But why am I talking about Johnson and Johnson?"
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?
"Now, how much does Johnson and Johnson charge for this this little drug of theirs?"
— Trump Just Opened Up A $400 BILLION Market (Get In Now)?